Market News (Page 1) - TendieTensor

Market News Page 1 of 234 • 5,840 articles

Class Action Filed Against Coupang, Inc. (CPNG) - February 17, 2026 Deadline to Join – Contact Levi & Korsinsky

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Class Action Filed Against Coupang, Inc. (CPNG) - February 17, 2026 Deadline to Join – Contact Levi & Korsinsky

12/26/2025 04:58 PM • Levi & Korsinsky has filed a class action securities lawsuit against Coupang, Inc. alleging the company made false statements regarding inadequate cybersecurity protocols that allowed a former employee to access sensitive customer information for nearly six months without detection. The complaint further alleges that defendants failed to properly report the data breach in SEC filings. Investors who suffered losses between August 6, 2025 and December 16, 2025 have until February 17, 2026 to join the lawsuit.

BMY - Mentioned as a strategic collaboration partner with no specific details provided
CPNG - The company faces serious allegations of securities fraud, inadequate cybersecurity protocols, unauthorized data access by a former employee, and failure to properly disclose the breach to the SEC. These violations expose the company to significant legal, regulatory, and financial risks.

#class action lawsuit #securities fraud #data breach #cybersecurity #SEC filing #investor losses

DeFi Technologies Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 30, 2026 to Discuss Your Rights – DEFT

GlobeNewswire Inc. • Levi & Korsinsky, Llp

DeFi Technologies Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 30, 2026 to Discuss Your Rights – DEFT

12/26/2025 04:58 PM • Levi & Korsinsky has filed a class action securities lawsuit against DeFi Technologies (NASDAQ: DEFT) alleging the company made false statements about its DeFi arbitrage strategy, understated competitive pressures, and was unlikely to meet its 2025 revenue guidance. Investors who suffered losses between May 12, 2025 and November 14, 2025 can join the lawsuit by January 30, 2026 with no out-of-pocket costs.

ALPMY - Mentioned as a strategic collaboration partner with no specific details provided
DEFT - The company is facing a securities fraud class action lawsuit alleging material misstatements regarding its core DeFi arbitrage strategy, competitive position, and inability to meet revenue guidance. These allegations indicate serious operational and disclosure failures that have negatively impacted investor value.

#securities fraud #class action lawsuit #DeFi arbitrage strategy #revenue guidance #false statements #investor losses

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Blue Owl Capital Inc.(OWL) Shareholders

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Blue Owl Capital Inc.(OWL) Shareholders

12/26/2025 04:57 PM • Law firm Levi & Korsinsky has filed a securities class action lawsuit against Blue Owl Capital Inc. on behalf of shareholders who suffered losses between February 6, 2025 and November 16, 2025. The complaint alleges the company made false statements and concealed material information regarding redemption pressures, undisclosed liquidity issues, and potential restrictions on business development company redemptions. Investors have until February 2, 2026 to request lead plaintiff status.

OWL - The company is the subject of a securities fraud class action lawsuit alleging false statements, concealment of material information regarding liquidity issues, and redemption pressures. These allegations indicate serious corporate governance and disclosure failures that negatively impact shareholder value.

#securities fraud #class action lawsuit #Blue Owl Capital Inc. #redemptions #liquidity issues #shareholder losses #material misstatement

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights – TLX

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights – TLX

12/26/2025 04:57 PM • Levi & Korsinsky, LLP has filed a class action securities lawsuit against Telix Pharmaceuticals Ltd. for alleged securities fraud between February 21, 2025 and August 28, 2025. The complaint alleges that defendants made false statements about prostate cancer therapeutic progress, overstated supply chain quality, and made materially misleading statements about business operations. Investors have until January 9, 2026 to request lead plaintiff status.

MRNA - Mentioned as a strategic collaboration partner with no specific details provided
TLX - The company is the subject of a securities fraud class action lawsuit alleging material misstatements about therapeutic progress, supply chain quality, and business operations. This represents significant legal and reputational risk to investors.

#securities fraud #class action lawsuit #false statements #prostate cancer therapeutics #supply chain #investor losses #lead plaintiff

Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 – PRGO

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 – PRGO

12/26/2025 04:57 PM • A class action securities lawsuit has been filed against Perrigo Company plc for alleged securities fraud between February 27, 2023 and November 4, 2025. The complaint alleges that defendants made false statements about the infant formula business acquired from Nestlé, including concealing significant underinvestment, manufacturing deficiencies, and the need for substantial capital expenditures. The lead plaintiff deadline is January 16, 2026.

REGN - Mentioned as a strategic collaboration partner with no specific details provided
PRGO - The company is the subject of a securities fraud class action lawsuit alleging false statements about its infant formula business, including concealed underinvestment, manufacturing deficiencies, and overstated financial results. These allegations represent serious legal and reputational risks.

#class action lawsuit #securities fraud #Perrigo Company plc #infant formula business #Nestlé acquisition #manufacturing deficiencies #financial misstatement #lead plaintiff deadline

StubHub Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – STUB

GlobeNewswire Inc. • Levi & Korsinsky, Llp

StubHub Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – STUB

12/26/2025 04:57 PM • Levi & Korsinsky, LLP has filed a class action securities lawsuit against StubHub Holdings, Inc. for alleged securities fraud related to its September 2025 IPO. The complaint alleges the company made false statements about vendor payment timing changes that materially impacted free cash flow and misled investors about business prospects. Investors who purchased stock during the IPO have until January 23, 2026 to request lead plaintiff status.

CELGr - Mentioned as a strategic collaboration partner with no specific details provided
STUB - The company is facing a securities fraud lawsuit alleging false statements and concealment of material information regarding vendor payment timing and free cash flow impacts, which directly harms investor confidence and stock value.

#securities fraud #class action lawsuit #IPO #free cash flow #vendor payments #misleading statements

Lost Money on Avantor, Inc.(AVTR)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Lost Money on Avantor, Inc.(AVTR)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

12/26/2025 04:56 PM • Levi & Korsinsky, LLP has filed class action securities lawsuits against Avantor, Inc. (AVTR), Coupang, Inc. (CPNG), and DeFi Technologies (DEFT) alleging securities fraud. Avantor investors claim the company made false statements about its competitive positioning and concealed negative effects from increased competition during March 5, 2024 to October 28, 2025. Investors who suffered losses during the relevant periods can join the lawsuits at no cost.

BACpE - Buffett trimmed the position by 26.3 million shares, suggesting a measured approach to the financial sector
AVTR - Company is subject to securities fraud allegations involving false statements about competitive positioning and concealment of negative competitive effects, resulting in investor losses.

#class action lawsuit #securities fraud #investor losses #false statements #competitive positioning #lead plaintiff deadline

Levi & Korsinsky Reminds Stride, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 – LRN

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Levi & Korsinsky Reminds Stride, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 – LRN

12/26/2025 04:56 PM • A class action securities lawsuit has been filed against Stride, Inc. (LRN) alleging securities fraud between October 22, 2024 and October 28, 2025. The complaint claims Stride inflated enrollment numbers, cut staffing costs beyond statutory limits, ignored compliance requirements including background checks and special education services, suppressed whistleblowers, and lost enrollments. Investors have until January 12, 2026 to request lead plaintiff status.

BACpB - Buffett trimmed the position by 26.3 million shares, suggesting a measured approach to the financial sector
LRN - The company faces serious allegations of securities fraud including inflating enrollment numbers, violating staffing requirements, ignoring compliance and special education mandates, suppressing whistleblowers, and losing enrollments. These allegations represent significant operational, legal, and financial risks.

#class action lawsuit #securities fraud #enrollment inflation #ghost students #staffing violations #compliance violations #whistleblower suppression #lead plaintiff deadline

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Integer Holdings Corporation (ITGR) Shareholders

GlobeNewswire Inc. • Levi & Korsinsky, Llp

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Integer Holdings Corporation (ITGR) Shareholders

12/26/2025 04:56 PM • Levi & Korsinsky has filed a securities class action lawsuit against Integer Holdings Corporation on behalf of shareholders who suffered losses between July 25, 2024 and October 22, 2025. The complaint alleges that Integer made false statements about its competitive position in the electrophysiology manufacturing market, overstated customer demand visibility, and mischaracterized electrophysiology devices as a growth driver. Investors have until February 9, 2026 to request lead plaintiff status.

BAC - Buffett trimmed the position by 26.3 million shares, suggesting a measured approach to the financial sector
ITGR - The company is the subject of a securities fraud class action lawsuit alleging material misstatements about its competitive position, customer demand visibility, and product growth prospects in the electrophysiology market. These allegations indicate significant operational and disclosure failures that resulted in shareholder losses.

#securities fraud #class action lawsuit #electrophysiology devices #false statements #shareholder losses #cardio & vascular segment

DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights – DXCM

GlobeNewswire Inc. • Levi & Korsinsky, Llp

DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights – DXCM

12/26/2025 04:56 PM • DexCom faces a class action securities lawsuit alleging the company made unauthorized design changes to its G6 and G7 glucose monitoring devices without FDA approval, rendering them less reliable and presenting health risks to users. The complaint claims defendants overstated the devices' enhancements and concealed the true scope of issues, exposing the company to regulatory scrutiny and significant financial harm. Investors who suffered losses between January 8, 2024 and September 17, 2025 can join the lawsuit.

DXCM - The company faces serious allegations of securities fraud, unauthorized product design changes, FDA violations, and concealment of health risks associated with its medical devices. These factors pose significant legal, regulatory, and reputational risks that negatively impact investor confidence and shareholder value.

#securities fraud #class action lawsuit #glucose monitoring devices #FDA violations #product reliability #investor losses

You Don’t Need Big Money for These 3 Under-$30 Stock Plays

Investing.com • Chris Markoch

You Don’t Need Big Money for These 3 Under-$30 Stock Plays

12/26/2025 02:45 PM • The article highlights three under-$30 stocks suitable for investors with limited capital: Nintendo (NTDOY), which faces RAM cost pressures but maintains strong Switch 2 sales forecasts; NU Holdings (NU), a Latin American fintech showing 61% YTD growth with expansion plans; and Carnival Cruise Lines (CCL), which has recovered with 21% YTD gains and reinstated its dividend.

AMGN - Mentioned as a strategic collaboration partner with no specific details provided
NTDOY - Despite recent 21.7% decline due to RAM cost pressures, the company increased Switch 2 sales forecast from 15M to 19M units and maintains current pricing through supplier contracts. Stock trades under $20, presenting a bargain opportunity if sales targets are met.

#under-$30 stocks #low-priced stocks #growth potential #Nintendo Switch 2 #fintech #cruise lines #dividend reinstatement

GlobeNewswire Inc. • Not Specified

Fitell Corporation Announces Interim Dividend and Shareholder Loyalty Program

12/26/2025 01:58 PM • Fitell Corporation announced an interim dividend of $0.10 per share payable January 13, 2026, and a one-time shareholder loyalty program offering up to $0.15 per share in three tranches for shareholders who maintain book-entry ownership for 30-90 days. The initiatives reflect the company's improved cash position and commitment to returning value to shareholders while supporting growth in fitness, corporate treasury management, and robotics ventures.

FTEL - The company is returning capital to shareholders through both an interim dividend and a loyalty program, indicating improved financial health and cash position. Management expressed confidence in the balance sheet and operational outlook, and the company is expanding into new growth areas including robotics ventures.

#interim dividend #shareholder loyalty program #book-entry transfer #capital return #fitness equipment #robotics joint-venture #2F Robotics

Microsoft Faces a Key Question: Compounder at Any Price or Accumulate Slowly

Investing.com • Itai Smidt

Microsoft Faces a Key Question: Compounder at Any Price or Accumulate Slowly

12/26/2025 01:48 PM • Microsoft trades at $486.72 with a P/E of 34.65, priced as a premium compounder. The company shows strong fundamentals with 18.43% revenue growth, 25.15% EPS growth, and 35.72% net margins. However, the valuation depends on three critical pillars: AI CapEx normalization by FY2028, continued Azure/AI growth at high double digits, and monetization of OpenAI/Anthropic relationships. Material risks include potential AI infrastructure overbuild, competition from Google and Amazon, and OpenAI financing/governance risks. Despite these risks, the analyst rates MSFT as a Buy given its strong financial performance and structural advantages.

MSFT - Strong financial metrics (18%+ revenue growth, 25%+ EPS growth, 35%+ net margins, 20%+ return on capital) and strategic positioning in AI/cloud with Azure growing at 39%. Analyst rates as Buy despite premium valuation. Positive outlook contingent on successful AI CapEx deployment and continued market dominance.

#Microsoft #AI infrastructure #Azure #valuation #CapEx #OpenAI #cloud computing #earnings growth #competitive risks

DEADLINE ALERT for FCX, PRGO, JYD, STUB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

GlobeNewswire Inc. • Law Offices Of Howard G. Smith

DEADLINE ALERT for FCX, PRGO, JYD, STUB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

12/26/2025 12:56 PM • Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Freeport-McMoRan (FCX) for safety issues at its Indonesian mine, Perrigo Company (PRGO) for undisclosed problems with its acquired infant formula business, Jayud Global Logistics (JYD) for involvement in a fraudulent stock promotion scheme, and StubHub Holdings (STUB) for misleading cash flow reporting. Investors have until January 2026 to file lead plaintiff motions.

FCX - Company faces securities fraud allegations for failing to disclose inadequate safety measures at its Grasberg mine in Indonesia, creating undisclosed regulatory and reputational risks.

#securities fraud #class action lawsuit #lead plaintiff deadline #false statements #misleading disclosures #investor losses

Deadline Alert: CarMax, Inc. (KMX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: CarMax, Inc. (KMX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/26/2025 12:49 PM • CarMax faces a securities fraud class action lawsuit after the company disclosed significant revenue and profit declines in Q2 2026 results on September 25, 2025. The lawsuit alleges CarMax made materially false statements about growth prospects, which were allegedly driven by temporary tariff-related speculation rather than sustainable business fundamentals. The stock fell 20.1% following the disclosure. Investors have until January 2, 2026 to file a lead plaintiff motion.

PIPR - Mentioned as conference host facilitating investor interactions
KMX - CarMax disclosed significant financial deterioration (6% revenue decline, 7.2% retail vehicle revenue decline, 5.6% gross profit decline) and faces securities fraud allegations for allegedly overstating growth prospects. The stock experienced a sharp 20.1% decline on the news, and the company is accused of misleading investors about the sustainability of its earlier growth.

#securities fraud #class action lawsuit #revenue decline #misleading statements #tariff speculation #inventory right-sizing #loan loss provisions

Silver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What's Moving Markets Friday?

Benzinga • Piero Cingari

Silver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What's Moving Markets Friday?

12/26/2025 12:47 PM • Precious and industrial metals surged on December 26, 2025, with silver up 6% to $76/oz, platinum up 8%, and palladium up 11%, driven by supply crunches in Asian markets. Silver and platinum are on track for their best years since 1978 and on record, respectively. Gold rose 1.3% to $4,550/oz while copper climbed 4.6%. Among equities, copper producer Freeport-McMoRan led gains at +3%, while the S&P 500 remained flat near 5,930 points.

FCX - Copper producer led S&P 500 gainers with +3% gain, benefiting from copper's 4.6% climb as it recovers from July selloff.

#precious metals #silver #platinum #palladium #supply crunch #copper #gold #market volatility #year-to-date gains

Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026

Investing.com • Leo Miller

Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026

12/26/2025 12:44 PM • Eli Lilly released promising clinical trial data for two next-generation weight loss and diabetes drugs in late 2025. Orforglipron, an oral GLP-1 pill, showed patients maintained 80-95% of weight loss when switching from injectables. Retatrutide demonstrated superior weight loss (28.7% vs 20.2% for current drugs) but had higher discontinuation rates. The company faces critical FDA approval decisions and additional trial readouts in 2026 that could significantly impact its stock performance.

LLY - Company demonstrated strong clinical trial results for next-generation drugs with potential to expand market reach through oral formulations and superior weight loss efficacy. Stock gained 71% year-to-date and company achieved $1 trillion market cap. However, sentiment is tempered by execution risks including FDA approval uncertainty and elevated discontinuation rates in retatrutide trials.

#weight loss drugs #GLP-1 medications #orforglipron #retatrutide #clinical trial data #FDA approval #pharmaceutical innovation #tirzepatide #Zepbound #Mounjaro

Deadline Alert: Primo Brands Corporation (PRMB) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Primo Brands Corporation (PRMB) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/26/2025 12:43 PM • Glancy Prongay & Murray LLP is alerting Primo Brands Corporation investors to a January 12, 2026 deadline to file a lead plaintiff motion in a securities fraud class action. The lawsuit alleges that Primo Brands made materially false statements regarding its merger integration with BlueTriton Brands, failing to disclose major supply disruptions and operational issues. Stock prices fell significantly following disclosures in August 2025 (9.1% decline) and November 2025 (36.2% decline over two days) when the company admitted integration problems and replaced its CEO.

QCOM - Invested in Classiq and aligned with vision of enabling intelligent edge and cloud systems
PRMB - The company is the subject of a securities fraud lawsuit alleging material misstatements and non-disclosure of merger integration problems and supply disruptions. Stock declined 9.1% in August 2025 and 36.2% in November 2025 following negative operational disclosures and CEO replacement, indicating significant investor losses and loss of confidence.

#securities fraud #class action lawsuit #merger integration #supply disruptions #stock price decline #CEO replacement #guidance reduction

Deadline Alert: Sprouts Farmers Market, Inc. (SFM) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Sprouts Farmers Market, Inc. (SFM) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/26/2025 12:43 PM • A class action lawsuit has been filed against Sprouts Farmers Market (SFM) alleging securities fraud. The company announced weaker-than-expected Q3 2025 results with comparable-store sales growth of 5.9% and slashed full-year guidance to flat to 2% growth, citing previously undisclosed challenging comparisons and softening consumer demand. The stock fell 26.1% on the news. Investors who purchased SFM securities between June 4 and October 29, 2025 have until January 26, 2026 to file a lead plaintiff motion.

SFM - The company is facing a securities fraud lawsuit alleging material misstatements and non-disclosure of adverse business conditions. Q3 results significantly missed expectations with comparable-store sales of 5.9% versus prior guidance, full-year guidance was slashed to flat to 2% growth, and the stock experienced a sharp 26.1% decline. The lawsuit alleges defendants failed to disclose weakening consumer demand and unsustainable growth metrics.

#securities fraud #class action lawsuit #comparable-store sales #guidance reduction #stock decline #investor losses #misleading statements

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Charming Medical Limited (MCTA) Shareholders to Inquire About Securities Fraud Class Action

Benzinga • Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Charming Medical Limited (MCTA) Shareholders to Inquire About Securities Fraud Class Action

12/26/2025 12:43 PM • A securities fraud class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) on behalf of investors who purchased shares between October 10 and November 12, 2025. The SEC halted trading of MCTA securities due to potential market manipulation involving social media-based fraudulent stock promotion schemes. The complaint alleges that company defendants made materially false statements and failed to disclose the fraudulent promotion scheme, insider share dumping, and artificial trading activity driving the stock price.

MCTA - The company is the subject of a securities fraud class action lawsuit, SEC trading halt, and allegations of involvement in a fraudulent stock promotion scheme involving market manipulation, false statements, insider share dumping, and artificial trading activity designed to inflate stock price.

#securities fraud #class action lawsuit #market manipulation #social media promotion #SEC trading halt #shareholder rights #stock price inflation

Deadline Alert: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

12/26/2025 12:39 PM • Glancy Prongay & Murray LLP is alerting Stride, Inc. investors about a class action securities fraud lawsuit with a January 12, 2026 deadline to file a lead plaintiff motion. The lawsuit alleges that Stride made false statements and failed to disclose material facts about inflated enrollment numbers through 'ghost students,' inadequate staffing, compliance violations, and suppressed whistleblowers. The company's stock fell 11.7% on September 15, 2025 following fraud allegations and another 54.4% on October 29, 2025 after disappointing Q1 fiscal 2026 results.

IONQ - Invested in Classiq and sees partnership as enabling cutting-edge quantum applications
LRN - Stride faces serious allegations of securities fraud including inflating enrollment numbers with 'ghost students,' ignoring compliance requirements, suppressing whistleblowers, and making materially false statements to investors. The company experienced significant stock price declines (11.7% and 54.4%) following disclosure of these issues and disappointing financial results, indicating substantial investor losses and reputational damage.

#securities fraud #class action lawsuit #enrollment fraud #ghost students #compliance violations #stock decline #lead plaintiff #material misstatement

The Motley Fool • Bram Berkowitz

Ed Yardeni Steps Back From the "Magnificent Seven" and Bets on the Impressive 493 Instead

12/26/2025 12:37 PM • Investment strategist Ed Yardeni is shifting from a bullish stance on the Magnificent Seven tech stocks to a more neutral position, instead favoring the remaining 493 S&P 500 companies. He believes all companies are becoming technology companies and recommends focusing on industrials, financials, and healthcare sectors, which offer better valuations and risk-reward scenarios compared to expensive AI-driven tech stocks.

IONQ.WS - Invested in Classiq and sees partnership as enabling cutting-edge quantum applications
MAGX - Yardeni is shifting from bullish to neutral on these stocks due to concerns about excessive valuations, concentration risk (35% of S&P 500), and uncertainty about whether AI infrastructure investments will deliver promised returns. Increased competition from smaller tech companies and each other may erode margins.

#Magnificent Seven #S&P 500 #tech stocks #artificial intelligence #valuations #healthcare sector #financials sector #industrials sector #market concentration

ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 11:50 AM • The Schall Law Firm is seeking investors in a class action securities fraud lawsuit against Alexandria Real Estate Equities, Inc. (ARE) for making false and misleading statements about leasing spreads and occupancy growth for its life-science properties between January 27, 2025 and October 27, 2025. Investors who suffered losses are encouraged to join the case by January 26, 2026.

ARE - The company is accused of making false and misleading statements to investors regarding leasing spreads and occupancy growth for its life-science properties, resulting in investor losses. A securities fraud class action lawsuit has been filed against the company for violations of the Securities Exchange Act.

#securities fraud #class action lawsuit #Alexandria Real Estate Equities #misleading statements #leasing spreads #occupancy growth #shareholder rights

JYD Investors Have Opportunity to Lead Jayud Global Logistics Limited Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

JYD Investors Have Opportunity to Lead Jayud Global Logistics Limited Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 11:40 AM • The Schall Law Firm is seeking investors who purchased Jayud Global Logistics Limited (NASDAQ: JYD) securities between April 21, 2023 and April 30, 2025 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements, benefited from a fraudulent stock promotion scheme involving impersonated financial professionals, and used offshore accounts to dump inflated shares.

JYD - The company is accused of making false and misleading statements, participating in fraudulent stock promotion schemes with impersonated financial professionals, and using offshore accounts to dump shares at inflated prices, resulting in investor losses.

#securities fraud #class action lawsuit #false statements #stock promotion scheme #offshore accounts #share dumping #investor losses

PRMB Investors Have Opportunity to Lead Primo Brands Corporation Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

PRMB Investors Have Opportunity to Lead Primo Brands Corporation Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 11:00 AM • The Schall Law Firm is seeking investors who purchased Primo Brands Corporation (PRMB) securities between June 2024 and November 2025 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about its merger with BlueTriton Brands, claiming it was proceeding 'flawlessly' while failing to disclose material facts about integration progress. Investors are encouraged to contact the firm before January 12, 2026.

TTE - Proactively transitioning to renewable energy, 17% clean energy growth in 2024, 6.1% dividend yield, committed to energy transition unlike peers
PRMB - The company is accused of making false and misleading statements regarding its merger with BlueTriton Brands, failing to disclose material facts about integration progress, and misrepresenting the merger as proceeding 'flawlessly' when it was not. This resulted in investor losses and triggered a securities fraud class action lawsuit.

#securities fraud #class action lawsuit #Primo Brands Corporation #merger #BlueTriton Brands #false statements #investor losses